Evaluation of Laser Acupuncture in the treatment of Fatty liver
- Conditions
- Fatty liver disease with 2 and 3 grading.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20111121008146N45
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
In the form of a randomized blinded clinical trial, patients with fibrotic fatty liver with increased liver enzymes (AST and ALT above 40) aged 20 to 70 years who refer to Taleghani Hospital for treatment are examined in terms of inclusion criteria. The criteria for entering the study include grade 2 and 3 fatty liver with increased liver enzymes confirmed by fibroscan and age 20 to 70 years, which is full consent to participate in the study and complete the treatment and follow-up process.
Patients with diabetes, pregnant and lactating, hyperlipidemia and hypercholesterolemia, taking any medication in the last month, hepatitis, cardiovascular patients, hypertension, hyper and hypothyroid, fibroid and polycystic ovary, hormonal disorders, age under 20 and over 50 years and receiving laser for any other reason are excluded from the study process.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Steatosis grading. Timepoint: Before and 1, 3, 6 months after intervention. Method of measurement: Fibrscan.;Fibrosis grading. Timepoint: Before and 1, 3, 6 months after intervention. Method of measurement: Fibrscan.;Biochemical profile. Timepoint: Before and 1, 3, 6 months after intervention. Method of measurement: Blood sample.
- Secondary Outcome Measures
Name Time Method